Brooks Automation, Inc. Stock

$29.19

4.31% today

Nasdaq, Aug 12, 09:15 pm CET

ISIN

US1143401024

Symbol

AZTA

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Life Sciences Tools & Services

Overview Dividends Analysts Charts News Strategies

Brooks Automation, Inc. Stock price

$27.98

-26.69 48.82% 5Y

Nasdaq, Closing price Mon, Aug 11 2025

-1.05 3.62%

ISIN

US1143401024

Symbol

AZTA

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Life Sciences Tools & Services

Key metrics

Basic

Market capitalization

$1.3b

Enterprise Value

$963.7m

Net debt

Cash

$318.9m

Shares outstanding

45.8m

Valuation (TTM | estimate)

P/E

negative | 62.3

P/S

2.1 | 2.1

EV/Sales

1.6 | 1.6

EV/FCF

21.1

P/B

0.8

Dividends

DPS

$0.00

Yield 1Y | 5Y

0.0% | 0.3%

Growth 1Y | 5Y

- | -100.0%

Payout 1Y | 3Y

0.0% | 0.4%

Increased

0 Years

Financials (TTM | estimate)

Revenue

$604.9m | $608.4m

EBITDA

$36.2m | $65.0m

EBIT

$-34.5m | $10.3m

Net Income

$-111.6m | $20.6m

Free Cash Flow

$45.7m

Growth (TTM | estimate)

Revenue

-8.2% | -7.3%

EBITDA

217.8% | 264.2%

EBIT

55.6% | 114.1%

Net Income

28.4% | 112.5%

Free Cash Flow

11.7%

Financial Health

Equity Ratio

84.2%

Return on Equity

-9.3%

ROCE

-1.9%

ROIC

-3.5%

Debt/Equity

EPS

$-2.4

FCF per Share

$1.0

Short interest

17.1%

Employees

Rev per Employee

$220.0k

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Get Started for Free Today

Brooks Automation, Inc. Stock Analysis

Unlock Scores for Free

??

13 Analysts have issued a Brooks Automation, Inc. forecast:

8x Hold

62%

4x Sell

31%

More details on Analyst Estimates Including Price Targets

13 Analysts have issued a Brooks Automation, Inc. forecast:

Buy

Hold

62%

Sell

31%

Analyst Estimates with Stock Price Targets

Financial data from Brooks Automation, Inc.

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Jun '25		+/- %
Revenue	605 605	8% 8% 100%
- Direct Costs	333 333	16% 16% 55%
Gross Profit	272 272	4% 4% 45%
- Selling and Administrative Expenses	278 278	9% 9% 46%
- Research and Development Expense	28 28	17% 17% 5%
EBITDA	36 36	218% 218% 6%
- Depreciation and Amortization	71 71	21% 21% 12%
EBIT (Operating Income) EBIT	-34 -34	56% 56% -6%
Net Profit	-112 -112	28% 28% -18%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Brooks Automation, Inc. Stock News

Neutral

Seeking Alpha

●

7 days ago

Azenta, Inc. (AZTA) Q3 2025 Earnings Call Transcript

Azenta, Inc. (NASDAQ:AZTA ) Q3 2025 Earnings Conference Call August 6, 2025 8:30 AM ET Company Participants John P. Marotta - President, CEO & Director Lawrence Y.

Positive

The Motley Fool

●

7 days ago

Azenta (AZTA) Q3 EPS Jumps 36%

Neutral

PRNewsWire

●

7 days ago

Azenta Reports Third Quarter Results for Fiscal 2025, Ended June 30, 2025; Reiterates Full Year Fiscal 2025 Guidance

BURLINGTON, Mass. , Aug. 5, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the third quarter ended June 30, 2025.

More Brooks Automation, Inc. News

Company Profile

Brooks Automation, Inc. engages in the provision of automation and cryogenic solutions for multiple markets, including semiconductor capital equipment and life science biological sample management and storage. It operates through the Brooks Semiconductor Solutions Group and Brooks Life Sciences segments. The Brooks Semiconductor Solutions Group segment include atmospheric and vacuum robots, robotic modules and tool automation systems that provide precision handling and clean wafer environments, as well as cryogenic pumps and compressors that provide vacuum pumping and thermal management solutions used to create and control critical process vacuum applications. The Brooks Life Sciences segment provides automated cold sample management systems for compound and biological sample storage, equipment for sample preparation and handling, consumables, and parts and support services to a range of life science customers including pharmaceutical companies, biotechnology companies, bio-banks and research institutes. The company was founded in 1978 and is headquartered in Chelmsford, MA.

Head office	United States
CEO	John Marotta
Employees	3,000
Founded	1978
Website	www.azenta.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now